{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:06:03Z","timestamp":1788231963821,"version":"build-2803163510"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Open access funding enabled and organized by Projekt DEAL"},{"DOI":"10.13039\/501100006254","name":"Ruhr-Universit\u00e4t Bochum","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006254","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The inpatient Parkinson's Disease Multimodal Complex Therapy (PD-MCT) is a specialized therapeutic concept for people with Parkinson's disease (PD), that is increasingly applied with great success in Germany. It provides a core element of the provision of care for the more than 400,000 PD patients in Germany. In this expert review, we describe the basic elements of PD-MCT in Germany with its structural features, treatment team, therapeutic process and contents. The most recent data on the core neurologic value of PD-MCT are presented with its effect sizes and influencing factors. In detail, eight observational studies have demonstrated relevant effectiveness, with an average improvement of 7.8 points on the Movement Disorder Society Unified Parkinson\u2019s Disease Rating Scale, Part III. Expert considerations of a PD-MCT target population are depicted as well as its additional values including multidisciplinary assessment and care, differential diagnosis and consideration of comorbidities, patient and caregiver education, improvement of nutrition, polypharmacy and therapeutic drug monitoring. The review concludes with a viewpoint on the possibilities for optimization and the future needs for PD-MCT.<\/jats:p>","DOI":"10.1007\/s00702-025-02963-7","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T11:30:03Z","timestamp":1749727803000},"page":"335-345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Parkinson's Disease Multidisciplinary Complex Therapy (PD-MCT): appreciation of its current function for the treatment of people with Parkinson\u2019s disease in Germany and the needs of future development"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0700-4197","authenticated-orcid":false,"given":"Raphael","family":"Scherbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"H\u00f6llerhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Klebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Riederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Schr\u00f6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Weise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Woitalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"T\u00f6nges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"issue":"6","key":"2963_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323(6):548\u2013560","journal-title":"JAMA"},{"key":"2963_CR2","doi-asserted-by":"crossref","unstructured":"Br\u00fccher S, Jakob V, Klucken J, Stallforth S, Winterholler M (2019) 371: inpatient parkinson complex therapy and gait: a pilot study using three dimensional gait analysis (3D-GA). In: Abstracts of the German congress on Parkinson\u2019s disease and movement disorders (Deutscher Kongress f\u00fcr Parkinson und Bewegungsst\u00f6rungen), 7\u20139 March 2019, D\u00fcsseldorf, pp 645\u2013693","DOI":"10.1007\/s00702-019-01978-1"},{"issue":"3","key":"2963_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2165\/00003088-198713030-00002","volume":"13","author":"JM Cedarbaum","year":"1987","unstructured":"Cedarbaum JM (1987) Clinical pharmacokinetics of anti-parkinsonian drugs. Clin Pharmacokinet 13(3):141\u2013178","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"2963_CR4","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1002\/mds.28552","volume":"36","author":"I Claus","year":"2021","unstructured":"Claus I, Muhle P, Czechowski J, Ahring S, Labeit B, Suntrup-Krueger S, Wiendl H, Dziewas R, Warnecke T (2021) Expiratory muscle strength training for therapy of pharyngeal dysphagia in Parkinson\u2019s disease. Mov Disord 36(8):1815\u20131824","journal-title":"Mov Disord"},{"issue":"1","key":"2963_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00702-015-1443-z","volume":"123","author":"I Csoti","year":"2016","unstructured":"Csoti I, Jost WH, Reichmann H (2016) Parkinson\u2019s disease between internal medicine and neurology. J Neural Transm (Vienna, Austria: 1996) 123(1):3\u201317","journal-title":"J Neural Transm (Vienna, Austria: 1996)"},{"issue":"12","key":"2963_CR6","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.3390\/brainsci12121735","volume":"12","author":"E Cubo","year":"2022","unstructured":"Cubo E, Delgado-L\u00f3pez PD (2022) Telemedicine in the management of parkinson\u2019s disease: achievements, challenges, and future perspectives. Brain Sci 12(12):1735","journal-title":"Brain Sci"},{"issue":"2","key":"2963_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00702-021-02306-2","volume":"128","author":"W Danysz","year":"2021","unstructured":"Danysz W, Dekundy A, Scheschonka A, Riederer P (2021) Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials. J Neural Transm 128(2):127\u2013169","journal-title":"J Neural Transm"},{"issue":"3","key":"2963_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4103\/1673-5374.320965","volume":"17","author":"A de Iuliis","year":"2022","unstructured":"de Iuliis A, Montinaro E, Fatati G, Plebani M, Colosimo C (2022) Diabetes mellitus and Parkinson\u2019s disease: dangerous liaisons between insulin and dopamine. Neural Regen Res 17(3):523\u2013533","journal-title":"Neural Regen Res"},{"key":"2963_CR9","unstructured":"Decher L, Carapezza TLC, M\u00fcgge F, Kleinholdermann U, Pedrosa D (2023) 484: multimodale evaluation der Parkinson-komplex-behandlung. In: DGN-Kongress 2023\u2014abstracts"},{"issue":"4","key":"2963_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3233\/JPD-181383","volume":"8","author":"J Domingos","year":"2018","unstructured":"Domingos J, Keus SHJ, Dean J, de Vries NM, Ferreira JJ, Bloem BR (2018) The European physiotherapy guideline for Parkinson\u2019s disease: implications for neurologists. J Parkinsons Dis 8(4):499\u2013502","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"2963_CR11","volume":"4","author":"M Ernst","year":"2024","unstructured":"Ernst M, Folkerts A-K, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E (2024) Physical exercise for people with Parkinson\u2019s disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev 4(4):CD013856","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"2963_CR12","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","volume":"140","author":"S-M Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad S-M, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression. Brain 140(7):1959\u20131976","journal-title":"Brain"},{"issue":"8","key":"2963_CR13","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/jnnp-2017-316437","volume":"89","author":"D Ferrazzoli","year":"2018","unstructured":"Ferrazzoli D, Ortelli P, Zivi I, Cian V, Urso E, Ghilardi MF, Maestri R, Frazzitta G (2018) Efficacy of intensive multidisciplinary rehabilitation in Parkinson\u2019s disease. A randomised controlled study. J Neurol Neurosurg Psychiatry 89(8):828\u2013835","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2963_CR14","unstructured":"Federal Institute for Drugs and Medical Devices (2024) OPS Version 2025. Kapitel 8: Nicht operative therapeutische Ma\u00dfnahmen. https:\/\/klassifikationen.bfarm.de\/ops\/kode-suche\/htmlops2025\/index.htm. Accessed 10 Mar 2025"},{"issue":"8","key":"2963_CR15","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.27372","volume":"33","author":"SH Fox","year":"2018","unstructured":"Fox SH, Katzenschlager R, Lim S-Y, Barton B, de Bie RMA, Seppi K, Coelho M, Sampaio C (2018) International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease. Mov Disord 33(8):1248\u20131266","journal-title":"Mov Disord"},{"issue":"2","key":"2963_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1177\/1545968311416990","volume":"26","author":"G Frazzitta","year":"2012","unstructured":"Frazzitta G, Bertotti G, Riboldazzi G, Turla M, Uccellini D, Boveri N, Guaglio G, Perini M, Comi C, Balbi P, Maestri R (2012) Effectiveness of intensive inpatient rehabilitation treatment on disease progression in parkinsonian patients. A randomized controlled trial with 1-year follow-up. Neurorehabil Neural Repair 26(2):144\u2013150","journal-title":"Neurorehabil Neural Repair"},{"key":"2963_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2024.100239","volume":"10","author":"VSC Fung","year":"2024","unstructured":"Fung VSC, Aldred J, Arroyo MP, Bergquist F, Boon AJW, Bouchard M, Bray S, Dhanani S, Facheris MF, Fisseha N, Freire-Alvarez E, Hauser RA, Jeong A, Jia J, Kukreja P, Soileau MJ, Spiegel AM, Talapala S, Tarakad A, Urrea-Mendoza E, Zamudio J, Pahwa R (2024) Continuous subcutaneous foslevodopa\/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson\u2019s disease: considerations for initiation and maintenance. Clin Parkinsonism Relat Disord 10:100239","journal-title":"Clin Parkinsonism Relat Disord"},{"issue":"11","key":"2963_CR18","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3390\/brainsci11111460","volume":"11","author":"KG Heimrich","year":"2021","unstructured":"Heimrich KG, Prell T (2021) Short- and long-term effect of parkinson\u2019s disease multimodal complex treatment. Brain Sci 11(11):1460","journal-title":"Brain Sci"},{"key":"2963_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3389\/fneur.2018.00500","volume":"9","author":"S Heinzel","year":"2018","unstructured":"Heinzel S, Berg D, Binder S, Ebersbach G, Hickstein L, Herbst H, Lorrain M, Wellach I, Maetzler W, Petersen G, Schmedt N, Volkmann J, Woitalla D, Amelung V (2018) Do we need to rethink the epidemiology and healthcare utilization of Parkinson\u2019s disease in Germany? Front Neurol 9:500","journal-title":"Front Neurol"},{"issue":"1\u201302","key":"2963_CR20","first-page":"9","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gr\u00fcnder G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, M\u00f6ssner R, M\u00fcller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P (2018) Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 51(1\u201302):9\u201362","journal-title":"Pharmacopsychiatry"},{"key":"2963_CR21","unstructured":"H\u00f6glinger G, Trenkwalder C (2023) Parkinson-Krankheit, S2k-Leitlinie. In: Deutsche Gesellschaft f\u00fcr Neurologie (ed) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. www.dgn.org\/leitlinien"},{"key":"2963_CR22","unstructured":"Kalf JG, Swart BJ de, Bonnier M, Hofman M, Kanters J, Kocken J, Miltenburg M (2011) Guidelines for speech-language therapy in Parkinson\u2019s disease. http:\/\/www.parkinsonnet.info\/media\/14829977\/dutch_slp_guidelines-final.pdf. Accessed 10 Mar 2025"},{"issue":"6","key":"2963_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/BF01530764","volume":"4","author":"TJ Kiresuk","year":"1968","unstructured":"Kiresuk TJ, Sherman RE (1968) Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J 4(6):443\u2013453","journal-title":"Community Ment Health J"},{"key":"2963_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3389\/fneur.2019.00410","volume":"10","author":"T Koeglsperger","year":"2019","unstructured":"Koeglsperger T, Palleis C, Hell F, Mehrkens JH, B\u00f6tzel K (2019) Deep brain stimulation programming for movement disorders: current concepts and evidence-based strategies. Front Neurol 10:410","journal-title":"Front Neurol"},{"issue":"5","key":"2963_CR25","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/ene.15734","volume":"30","author":"V Leta","year":"2023","unstructured":"Leta V, Klingelhoefer L, Longardner K, Campagnolo M, Levent H\u00c7, Aureli F, Metta V, Bhidayasiri R, Chung-Faye G, Falup-Pecurariu C, Stocchi F, Jenner P, Warnecke T, Ray Chaudhuri K (2023) Gastrointestinal barriers to levodopa transport and absorption in Parkinson\u2019s disease. Eur J Neurol 30(5):1465\u20131480","journal-title":"Eur J Neurol"},{"key":"2963_CR26","doi-asserted-by":"publisher","first-page":"1036068","DOI":"10.3389\/fneur.2022.1036068","volume":"13","author":"PA LeWitt","year":"2022","unstructured":"LeWitt PA, Stocchi F, Arkadir D, Caraco Y, Adar L, Perlstein I, Case R, Giladi N (2022) The pharmacokinetics of continuous subcutaneous levodopa\/carbidopa infusion: findings from the ND0612 clinical development program. Front Neurol 13:1036068","journal-title":"Front Neurol"},{"issue":"3","key":"2963_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10286-020-00691-4","volume":"30","author":"F Leys","year":"2020","unstructured":"Leys F, Fanciulli A, Ndayisaba J-P, Granata R, Struhal W, Wenning GK (2020) Cardiovascular autonomic function testing in multiple system atrophy and Parkinson\u2019s disease: an expert-based blinded evaluation. Clin Auton Res 30(3):255\u2013263","journal-title":"Clin Auton Res"},{"issue":"6","key":"2963_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/14737175.2020.1771184","volume":"20","author":"SC Lidstone","year":"2020","unstructured":"Lidstone SC, Bayley M, Lang AE (2020) The evidence for multidisciplinary care in Parkinson\u2019s disease. Expert Rev Neurother 20(6):539\u2013549","journal-title":"Expert Rev Neurother"},{"key":"2963_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102823","volume":"76","author":"JJL Maas","year":"2024","unstructured":"Maas JJL, de Vries NM, IntHout J, Bloem BR, Kalf JG (2024) Effectiveness of remotely delivered speech therapy in persons with Parkinson\u2019s disease\u2014a randomised controlled trial. EClinicalMedicine 76:102823","journal-title":"EClinicalMedicine"},{"issue":"11","key":"2963_CR30","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1007\/s00415-023-11898-6","volume":"270","author":"F Mameli","year":"2023","unstructured":"Mameli F, Zirone E, Girlando R, Scagliotti E, Rigamonti G, Aiello EN, Poletti B, Ferrucci R, Ticozzi N, Silani V, Locatelli M, Barbieri S, Ruggiero F (2023) Role of expectations in clinical outcomes after deep brain stimulation in patients with Parkinson\u2019s disease: a systematic review. J Neurol 270(11):5274\u20135287","journal-title":"J Neurol"},{"issue":"11","key":"2963_CR31","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s40263-021-00862-5","volume":"35","author":"S Marmol","year":"2021","unstructured":"Marmol S, Feldman M, Singer C, Margolesky J (2021) Amantadine revisited: a contender for initial treatment in Parkinson\u2019s Disease? CNS Drugs 35(11):1141\u20131152","journal-title":"CNS Drugs"},{"issue":"4","key":"2963_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0891988719841721","volume":"32","author":"K Marumoto","year":"2019","unstructured":"Marumoto K, Yokoyama K, Inoue T, Yamamoto H, Kawami Y, Nakatani A, Fukazawa Y, Hosoe Y, Yamasaki A, Domen K (2019) Inpatient enhanced multidisciplinary care effects on the quality of life for Parkinson disease. A quasi-randomized controlled trial. J Geriatr Psychiatry Neurol 32(4):186\u2013194","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"5","key":"2963_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/WNF.0000000000000354","volume":"42","author":"NB Modi","year":"2019","unstructured":"Modi NB, Mittur A, Dinh P, Rubens R, Gupta S (2019a) Pharmacodynamics, efficacy, and safety of IPX203 in Parkinson disease patients with motor fluctuations. Clin Neuropharmacol 42(5):149\u2013156","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"2963_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/WNF.0000000000000314","volume":"42","author":"NB Modi","year":"2019","unstructured":"Modi NB, Mittur A, Rubens R, Khanna S, Gupta S (2019b) Single-dose pharmacokinetics and pharmacodynamics of IPX203 in patients with advanced Parkinson disease: a comparison with immediate-release carbidopa-levodopa and with extended-release carbidopa-levodopa capsules. Clin Neuropharmacol 42(1):4\u20138","journal-title":"Clin Neuropharmacol"},{"issue":"8","key":"2963_CR35","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/mds.26256","volume":"30","author":"M Monticone","year":"2015","unstructured":"Monticone M, Ambrosini E, Laurini A, Rocca B, Foti C (2015) In-patient multidisciplinary rehabilitation for Parkinson\u2019s disease. A randomized controlled trial. Mov Disord 30(8):1050\u20131058","journal-title":"Mov Disord"},{"issue":"6","key":"2963_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00702-017-1701-3","volume":"124","author":"T M\u00fcller","year":"2017","unstructured":"M\u00fcller T, \u00d6hm G, Eilert K, M\u00f6hr K, Rotter S, Haas T, K\u00fcchler M, L\u00fctge S, Marg M, Rothe H (2017) Benefit on motor and non-motor behavior in a specialized unit for Parkinson\u2019s disease. J Neural Transm 124(6):715\u2013720","journal-title":"J Neural Transm"},{"issue":"10","key":"2963_CR37","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00702-024-02828-5","volume":"131","author":"T M\u00fcller","year":"2024","unstructured":"M\u00fcller T, Gerlach M, Hefner G, Hiemke C, Jost WH, Riederer P (2024) Therapeutic drug monitoring in Parkinson\u2019s disease. J Neural Transm 131(10):1247\u20131262","journal-title":"J Neural Transm"},{"issue":"8","key":"2963_CR38","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s00115-024-01686-6","volume":"95","author":"A Naegele","year":"2024","unstructured":"Naegele A, Schwaninger I, Toenges L, Eggers C, Warnecke T, Weigand C, Klucken J (2024) Chat-Messenger-Nutzung in der Parkinson-Versorgung (Chat messenger use in the care of patients with Parkinson\u2019s disease). Nervenarzt 95(8):714\u2013720","journal-title":"Nervenarzt"},{"issue":"6","key":"2963_CR39","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/jamaneurol.2019.0033","volume":"76","author":"J Nonnekes","year":"2019","unstructured":"Nonnekes J, Ru\u017eicka E, Nieuwboer A, Hallett M, Fasano A, Bloem BR (2019) Compensation strategies for gait impairments in Parkinson disease: a review. JAMA Neurol 76(6):718\u2013725","journal-title":"JAMA Neurol"},{"issue":"2","key":"2963_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1517\/17425255.4.2.193","volume":"4","author":"D Nyholm","year":"2008","unstructured":"Nyholm D, Lennern\u00e4s H (2008) Irregular gastrointestinal drug absorption in Parkinson\u2019s disease. Expert Opin Drug Metab Toxicol 4(2):193\u2013203","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2963_CR41","doi-asserted-by":"publisher","first-page":"175628642412771","DOI":"10.1177\/17562864241277157","volume":"17","author":"J Oppermann","year":"2024","unstructured":"Oppermann J, Tschentscher V, Welzel J, Geritz J, Hansen C, Gold R, Maetzler W, Scherbaum R, T\u00f6nges L (2024) Clinical and device-based predictors of improved experience of activities of daily living after a multidisciplinary inpatient treatment for people with Parkinson\u2019s disease: a cohort study. Ther Adv Neurol Disord 17:17562864241277156","journal-title":"Ther Adv Neurol Disord"},{"issue":"12","key":"2963_CR42","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"key":"2963_CR43","first-page":"3366870","volume":"2021","author":"T Pu","year":"2021","unstructured":"Pu T, Huang M, Kong X, Wang M, Chen X, Feng X, Wei C, Weng X, Xu F (2021) Lee Silverman voice treatment to improve speech in Parkinson\u2019s disease: a systemic review and meta-analysis. Parkinson\u2019s Dis 2021:3366870","journal-title":"Parkinson's Dis"},{"key":"2963_CR44","doi-asserted-by":"publisher","first-page":"1205386","DOI":"10.3389\/fneur.2023.1205386","volume":"14","author":"M Putzolu","year":"2023","unstructured":"Putzolu M, Manzini V, Gambaro M, Cosentino C, Bonassi G, Botta A, Ravizzotti E, Avanzino L, Pelosin E, Mezzarobba S (2023) Home-based exercise training by using a smartphone app in patients with Parkinson\u2019s disease: a feasibility study. Front Neurol 14:1205386","journal-title":"Front Neurol"},{"key":"2963_CR45","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/bs.irn.2017.02.001","volume":"132","author":"MA Qamar","year":"2017","unstructured":"Qamar MA, Harington G, Trump S, Johnson J, Roberts F, Frost E (2017) Multidisciplinary care in Parkinson\u2019s disease. Int Rev Neurobiol 132:511\u2013523","journal-title":"Int Rev Neurobiol"},{"issue":"2","key":"2963_CR46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/14737175.2019.1561285","volume":"19","author":"DLM Radder","year":"2019","unstructured":"Radder DLM, de Vries NM, Riksen NP, Diamond SJ, Gross D, Gold DR, Heesakkers J, Henderson E, Hommel ALAJ, Lennaerts HH, Busch J, Dorsey RE, Andrejack J, Bloem BR (2019) Multidisciplinary care for people with Parkinson\u2019s disease. The new kids on the block! Expert Rev Neurother 19(2):145\u2013157","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"2963_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/JPD-160912","volume":"7","author":"MR Rafferty","year":"2017","unstructured":"Rafferty MR, Schmidt PN, Luo ST, Li K, Marras C, Davis TL, Guttman M, Cubillos F, Simuni T (2017) Regular exercise, quality of life, and mobility in Parkinson\u2019s disease: a longitudinal analysis of national Parkinson foundation quality improvement initiative data. J Parkinsons Dis 7(1):193\u2013202","journal-title":"J Parkinsons Dis"},{"issue":"9","key":"2963_CR48","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/mds.28097","volume":"35","author":"R Rajan","year":"2020","unstructured":"Rajan R, Brennan L, Bloem BR, Dahodwala N, Gardner J, Goldman JG, Grimes DA, Iansek R, Kov\u00e1cs N, McGinley J, Parashos SA, Piemonte MEP, Eggers C (2020) Integrated care in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 35(9):1509\u20131531","journal-title":"Mov Disord"},{"issue":"9","key":"2963_CR49","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00702-022-02509-1","volume":"129","author":"H Reichmann","year":"2022","unstructured":"Reichmann H, Csoti I, Koschel J, Lorenzl S, Schrader C, Winkler J, W\u00fcllner U (2022) Life style and Parkinson\u2019s disease. J Neural Transm 129(9):1235\u20131245","journal-title":"J Neural Transm"},{"issue":"2","key":"2963_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/cells8020151","volume":"8","author":"D Richter","year":"2019","unstructured":"Richter D, Bartig D, Muhlack S, Hartelt E, Scherbaum R, Katsanos AH, M\u00fcller T, Jost W, Ebersbach G, Gold R, Krogias C, T\u00f6nges L (2019) Dynamics of Parkinson\u2019s disease multimodal complex treatment in Germany from 2010\u20132016. Patient characteristics, access to treatment, and formation of regional centers. Cells 8(2):151","journal-title":"Cells"},{"key":"2963_CR51","doi-asserted-by":"crossref","unstructured":"Riederer P, Strobel S, Nagatsu T, Watanabe H, Chen X, L\u00f6schmann PA, Sian-Hulsmann J, Jost WH, M\u00fcller T, Dijkstra JM, Monoranu C (2025) Levodopa treatment: impacts and mechanisms throughout Parkinson's Disease progression. J Neural Transm (accepted)","DOI":"10.1007\/s00702-025-02893-4"},{"issue":"1","key":"2963_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/ana.26073","volume":"90","author":"M Rosebraugh","year":"2021","unstructured":"Rosebraugh M, Voight EA, Moussa EM, Jameel F, Lou X, Zhang GGZ, Mayer PT, Stolarik D, Carr RA, Enright BP, Liu W, Facheris MF, Kym PR (2021) Foslevodopa\/foscarbidopa: a new subcutaneous treatment for Parkinson\u2019s disease. Ann Neurol 90(1):52\u201361","journal-title":"Ann Neurol"},{"key":"2963_CR53","volume":"386","author":"CM Sackley","year":"2024","unstructured":"Sackley CM, Rick C, Brady MC, Woolley R, Burton C, Patel S, Masterson-Algar P, Nicoll A, Smith CH, Jowett S, Ives N, Beaton G, Dickson S, Ottridge R, Sharp L, Nankervis H, Clarke CE (2024) Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson\u2019s disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial. BMJ (Clinical Research Ed) 386:e078341","journal-title":"BMJ (Clinical Research Ed)"},{"issue":"7","key":"2963_CR54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435\u2013450","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"2963_CR55","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1001\/jamaneurol.2017.3517","volume":"75","author":"M Schenkman","year":"2018","unstructured":"Schenkman M, Moore CG, Kohrt WM, Hall DA, Delitto A, Comella CL, Josbeno DA, Christiansen CL, Berman BD, Kluger BM, Melanson EL, Jain S, Robichaud JA, Poon C, Corcos DM (2018) Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease. A phase 2 randomized clinical trial. JAMA Neurol 75(2):219\u2013226","journal-title":"JAMA Neurol"},{"issue":"8","key":"2963_CR56","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s00115-024-01666-w","volume":"95","author":"R Scherbaum","year":"2024","unstructured":"Scherbaum R, T\u00f6nges L (2024) Multidisziplin\u00e4re Komplextherapie der Parkinson-Krankheit\u202f: Eckpfeiler einer individualisierten Behandlung (Multidisciplinary complex treatment of parkinson\u2019s disease: cornerstone of an individualized treatment). Nervenarzt 95(8):704\u2013713","journal-title":"Nervenarzt"},{"issue":"4","key":"2963_CR57","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s00415-019-09657-7","volume":"267","author":"R Scherbaum","year":"2020","unstructured":"Scherbaum R, Hartelt E, Kinkel M, Gold R, Muhlack S, T\u00f6nges L (2020) Parkinson\u2019s disease multimodal complex treatment improves motor symptoms, depression and quality of life. J Neurol 267(4):954\u2013965","journal-title":"J Neurol"},{"issue":"11","key":"2963_CR58","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1007\/s00415-022-11257-x","volume":"269","author":"R Scherbaum","year":"2022","unstructured":"Scherbaum R, Moewius A, Oppermann J, Geritz J, Hansen C, Gold R, Maetzler W, T\u00f6nges L (2022) Parkinson\u2019s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study. J Neurol 269(11):6067\u20136085","journal-title":"J Neurol"},{"issue":"2","key":"2963_CR59","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C (2019) Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review. Mov Disord 34(2):180\u2013198","journal-title":"Mov Disord"},{"issue":"Suppl 3","key":"2963_CR60","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1002\/mds.22049","volume":"23","author":"K Sethi","year":"2008","unstructured":"Sethi K (2008) Levodopa unresponsive symptoms in Parkinson disease. Mov Disord 23(Suppl 3):S521\u2013S533","journal-title":"Mov Disord"},{"issue":"s1","key":"2963_CR61","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.3233\/JPD-230271","volume":"14","author":"E Steendam-Oldekamp","year":"2024","unstructured":"Steendam-Oldekamp E, van Laar T (2024) The effectiveness of inpatient rehabilitation in Parkinson\u2019s disease: a systematic review of recent studies. J Parkinsons Dis 14(s1):S93\u2013S112","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"2963_CR62","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41386-019-0448-y","volume":"45","author":"A Stefani","year":"2020","unstructured":"Stefani A, H\u00f6gl B (2020) Sleep in Parkinson\u2019s disease. Neuropsychopharmacology 45(1):121\u2013128","journal-title":"Neuropsychopharmacology"},{"key":"2963_CR63","unstructured":"Sturkenboom I, Thijssen MC, Gons-van Elsacker JJ, Jansen IJH, Maasdam A, Schulten M, Vijver-Visser D, Steultjens EJ, Bloem BR, Munneke M (2011) Guidelines for occupational therapy in Parkinson\u2019s disease rehabilitation. http:\/\/www.parkinsonnet.info\/media\/14820461\/ot_guidelines_final-npf__3_.pdf. Accessed 10 Mar 2025"},{"key":"2963_CR64","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1474-4422(14)70055-9","volume":"13","author":"IHWM Sturkenboom","year":"2014","unstructured":"Sturkenboom IHWM et al (2014) Efficacy of occupational therapy for patients with Parkinson\u2019s disease: a randomised controlled trial. Lancet Neurol 13:557\u2013566","journal-title":"Lancet Neurol"},{"issue":"1","key":"2963_CR65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/jgs.13866","volume":"64","author":"The American Geriatrics Society Expert Panel on Person-Centered Care","year":"2016","unstructured":"The American Geriatrics Society Expert Panel on Person-Centered Care (2016) Person-centered care: a definition and essential elements. J Am Geriatr Soc 64(1):15\u201318","journal-title":"J Am Geriatr Soc"},{"key":"2963_CR66","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/bs.irn.2017.05.015","volume":"134","author":"N Titova","year":"2017","unstructured":"Titova N, Chaudhuri KR (2017a) Personalized medicine and nonmotor symptoms in Parkinson\u2019s disease. Int Rev Neurobiol 134:1257\u20131281","journal-title":"Int Rev Neurobiol"},{"issue":"8","key":"2963_CR67","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/mds.27027","volume":"32","author":"N Titova","year":"2017","unstructured":"Titova N, Chaudhuri KR (2017b) Personalized medicine in Parkinson\u2019s disease: time to be precise. Mov Disord 32(8):1147\u20131154","journal-title":"Mov Disord"},{"issue":"8","key":"2963_CR68","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/mdc3.13089","volume":"7","author":"M Tofani","year":"2020","unstructured":"Tofani M, Ranieri A, Fabbrini G, Berardi A, Pelosin E, Valente D, Fabbrini A, Costanzo M, Galeoto G (2020) Efficacy of occupational therapy interventions on quality of life in patients with Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord Clin Pract 7(8):891\u2013901","journal-title":"Mov Disord Clin Pract"},{"key":"2963_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/jas\/skae078","volume":"102","author":"EEL Valente","year":"2024","unstructured":"Valente EEL, Klotz JL, Markmann RC, Trotta RJ, Edwards JL, May JB, Harmon DL (2024) Levodopa attenuates the feed intake reduction caused by ergot alkaloids in cattle. J Anim Sci 102:skae078","journal-title":"J Anim Sci"},{"issue":"11","key":"2963_CR70","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S1474-4422(19)30285-6","volume":"18","author":"NM van der Kolk","year":"2019","unstructured":"van der Kolk NM, de Vries NM, Kessels RPC, Joosten H, Zwinderman AH, Post B, Bloem BR (2019) Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson\u2019s disease: a double-blind, randomised controlled trial. Lancet Neurol 18(11):998\u20131008","journal-title":"Lancet Neurol"},{"key":"2963_CR71","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3389\/fneur.2019.01087","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel SP, El Aidy S (2019) Contributions of gut bacteria and diet to drug pharmacokinetics in the treatment of parkinson\u2019s disease. Front Neurol 10:1087","journal-title":"Front Neurol"},{"issue":"5","key":"2963_CR72","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3233\/JPD-225112","volume":"13","author":"T van Laar","year":"2023","unstructured":"van Laar T, Chaudhuri KR, Antonini A, Henriksen T, Tro\u0161t M (2023) Infusion therapies in the treatment of Parkinson\u2019s disease. J Parkinsons Dis 13(5):641\u2013657","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"2963_CR73","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/mds.28854","volume":"37","author":"A Vogel","year":"2022","unstructured":"Vogel A, Claus I, Ahring S, Gruber D, Haghikia A, Frank U, Dziewas R, Ebersbach G, Gandor F, Warnecke T (2022) Endoscopic characteristics of dysphagia in multiple system atrophy compared to Parkinson\u2019s disease. Mov Disord 37(3):535\u2013544","journal-title":"Mov Disord"},{"issue":"1","key":"2963_CR74","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12883-022-02647-9","volume":"22","author":"L Wagner","year":"2022","unstructured":"Wagner L, Hauptmann B, Hoffmann A-K, Jochems N, Schmeier B, Schrader A, Kohlmann T, Deck R (2022) Evaluation of an individualized, tablet-based physiotherapy training programme for patients with Parkinson\u2019s disease: the ParkProTrain study, a quasi-randomised controlled trial. BMC Neurol 22(1):176","journal-title":"BMC Neurol"},{"issue":"10","key":"2963_CR75","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00702-024-02807-w","volume":"131","author":"D Weise","year":"2024","unstructured":"Weise D, Claus I, Dresel C, Kalbe E, Liepelt-Scarfone I, Lorenzl S, Redecker C, Urban PP (2024) Multidisciplinary care in Parkinson\u2019s disease. J Neural Transm 131(10):1217\u20131227","journal-title":"J Neural Transm"},{"issue":"9","key":"2963_CR76","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00415-006-0207-y","volume":"253","author":"D Woitalla","year":"2006","unstructured":"Woitalla D, Goetze O, Kim JI, Nikodem AB, Schmidt WE, Przuntek H, M\u00fcller T (2006) Levodopa availability improves with progression of Parkinson\u2019s disease. J Neurol 253(9):1221\u20131226","journal-title":"J Neurol"},{"issue":"2","key":"2963_CR77","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1474-4422(17)30406-4","volume":"17","author":"JHL Ypinga","year":"2018","unstructured":"Ypinga JHL, de Vries NM, Boonen LHHM, Koolman X, Munneke M, Zwinderman AH, Bloem BR (2018) Effectiveness and costs of specialised physiotherapy given via ParkinsonNet. A retrospective analysis of medical claims data. Lancet Neurol 17(2):153\u2013161","journal-title":"Lancet Neurol"},{"issue":"1","key":"2963_CR78","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/mdc3.13578","volume":"10","author":"K Ziegler","year":"2022","unstructured":"Ziegler K, Messner M, Paulig M, Starrost K, Reuschenbach B, Fietzek UM, Ceballos-Baumann AO (2022) Activities of daily living are improved by inpatient multimodal complex treatment for PD\u2014a real-world cohort study. Mov Disord Clin Pract 10(1):42\u201354","journal-title":"Mov Disord Clin Pract"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02963-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-02963-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02963-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:03:39Z","timestamp":1769695419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-02963-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2963"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-02963-7","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}